BME222: Applied Biotechnology: Engineering Immunotherapeutic Drugs

*****COURSES ARE SUBJECT TO CHANGE*****

For students interested in careers in the biotech industry. Focus is applied technology, with particular emphasis on the application of cell engineering and protein engineering to solve problems encountered in the design and manufacturing of immunotherapeutic drugs produced by recombinant DNA technology. (Formerly Applied Biotechnology: Protein and Cell Engineering.) Enrollment is restricted to graduate students in biomolecular engineering; chemistry and biochemistry; and molecular, cellular, and developmental biology. Prior coursework in biochemistry, molecular biology, genetics, and cell biology recommended.

5 Credits

YearFallWinterSpringSummer
2017-18
2016-17
2015-16

While the information on this web site is usually the most up to date, in the event of a discrepancy please contact your adviser to confirm which information is correct.